Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 66776 - 66800 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Ritonavir	Approved Investigational	CCNA2	890	downregulated	Ritonavir results in decreased expression of CCNA2 mRNA	4q27	A24084
Ritonavir	Approved Investigational	CCNB1	891	downregulated	Ritonavir results in decreased expression of CCNB1 mRNA	5q13.2	A24084
Ritonavir	Approved Investigational	CCND2	894	downregulated	Ritonavir results in decreased expression of CCND2 mRNA	12p13.32	A24082 A24084
Ritonavir	Approved Investigational	CCNE2	9134	downregulated	Ritonavir results in decreased expression of CCNE2 mRNA	8q22.1	A24084
Ritonavir	Approved Investigational	CDK2	1017	downregulated	Ritonavir results in decreased expression of CDK2 mRNA	12q13.2	A24084
Ritonavir	Approved Investigational	CDK3	1018	upregulated	Ritonavir results in increased expression of CDK3 mRNA	17q25.1	A24084
Ritonavir	Approved Investigational	CDK4	1019	downregulated	Ritonavir results in decreased expression of CDK4 mRNA	12q14.1	A24084
Ritonavir	Approved Investigational	CDK5	1020	downregulated	Ritonavir results in decreased expression of CDK5 mRNA	7q36.1	A24084
Ritonavir	Approved Investigational	CDK6	1021	downregulated	Ritonavir results in decreased expression of CDK6 mRNA	7q21.2	A24084
Ritonavir	Approved Investigational	CDKN1A	1026	upregulated	Ritonavir results in increased expression of CDKN1A mRNA	6p21.2	A24084
Ritonavir	Approved Investigational	CDKN1B	1027	upregulated	Ritonavir results in increased expression of CDKN1B mRNA	12p13.1	A24084
Ritonavir	Approved Investigational	CDKN2B	1030	upregulated	Ritonavir results in increased expression of CDKN2B mRNA	9p21.3	A24084
Ritonavir	Approved Investigational	CYP1A1	1543	upregulated	Ritonavir results in increased expression of CYP1A1 mRNA	15q24.1	A24085
Ritonavir	Approved Investigational	CYP1A2	1544	upregulated	Ritonavir results in increased expression of CYP1A2 mRNA	15q24.1	A24085
Ritonavir	Approved Investigational	CYP2C19	1557	upregulated	Ritonavir results in increased expression of CYP2C19 mRNA	10q23.33	A24085
Ritonavir	Approved Investigational	CYP2C9	1559	upregulated	Ritonavir results in increased expression of CYP2C9 mRNA	10q23.33	A24085
Ritonavir	Approved Investigational	CYP3A4	1576	upregulated	Ritonavir results in increased expression of CYP3A4 mRNA	7q22.1	A20983
Ritonavir	Approved Investigational	CYP7A1	1581	downregulated	Ritonavir results in decreased expression of CYP7A1 mRNA	8q12.1	A24086
Ritonavir	Approved Investigational	E2F1	1869	downregulated	Ritonavir results in decreased expression of E2F1 mRNA	20q11.22	A24084
Ritonavir	Approved Investigational	E2F2	1870	downregulated	Ritonavir results in decreased expression of E2F2 mRNA	1p36.12	A24084
Ritonavir	Approved Investigational	E2F3	1871	downregulated	Ritonavir results in decreased expression of E2F3 mRNA	6p22.3	A24084
Ritonavir	Approved Investigational	FGF19	9965	upregulated	Ritonavir results in increased expression of FGF19 mRNA	11q13.3	A24086
Ritonavir	Approved Investigational	HMOX1	3162	upregulated	Ritonavir results in increased expression of HMOX1 mRNA	22q12.3	A24087
Ritonavir	Approved Investigational	MYC	4609	downregulated	Ritonavir results in decreased expression of MYC mRNA	8q24.21	A24082
Ritonavir	Approved Investigational	NOS3	4846	downregulated	Ritonavir results in decreased expression of NOS3 mRNA	7q36.1	A24088

Displaying entries 66776 - 66800 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability